Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases

Bibliography

• Mechoulam R, Gaoni Y. A total synthesis of DL-Delta-1-Tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 1965;20:32735
   Google Scholar
• Johnson KM, Dewey WL, Harris LS. Some structural requirement for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids. Mol Pharmacol 1976;12:345-52
   PubMedGoogle Scholar
• Norrod AG, Puffenbarger RA. Genetic polymorphisms of the endocannabinoid system. Chem Biodivers 2007;4:1926-32
   PubMed Web of Science ®Google Scholar
• Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, The endocannabinoid system: physiology and pharmacology. Alcohol 2005;40:2-14
   Google Scholar
• Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 2010;126:21-38
   PubMed Web of Science ®Google Scholar
• Matsuda LA, Lolait TI, Brownstein M, Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4
   PubMed Web of Science ®Google Scholar
• Howlett AC, Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 2000;108:53-70
   PubMed Web of Science ®Google Scholar
• Guzman M, Galve-Roperh I, Sanchez C. Ceramide; a new second messenger of cannabinoid action. Trends Pharmacol Sci 2001;22:19-22
   PubMed Web of Science ®Google Scholar
• Devane WA, Hanus L, Breuer A, Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9
   PubMed Web of Science ®Google Scholar
• Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002;66:101-21
   PubMed Web of Science ®Google Scholar
• Bisogno T. Endogenous cannabinoids: structure and metabolism. J Neuroendocrinol 2008;20(Suppl 1):1-9
   PubMed Web of Science ®Google Scholar
• Bari M, Battista N, Fezza F, New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 2006;6:257-68
   PubMed Web of Science ®Google Scholar
• Gerard CM, Mollereau C, Vassart G, Molecular cloning of a human cannabinoid receptor which is also expressed in the testis. Biochem J 1991;279:129-34
   PubMed Web of Science ®Google Scholar
• Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5
   PubMed Web of Science ®Google Scholar
• Shire D, Calandra B, Bouaboula M, Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci 1999;65:627-35
   PubMedGoogle Scholar
• Onaivi ES, Leonard CM, Ishiquro H, Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 2002;66:307-44
   PubMed Web of Science ®Google Scholar
• Onaivi ES. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006;54:231-46
   PubMedGoogle Scholar
• Berdyshev EV. Cannabinoid receptors and the regulation of immune response. Chem Phys Lipids 2000;108:169-90
   PubMed Web of Science ®Google Scholar
• Gong JP, Onaivi ES, Ishiquro H, Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006;1071:10-23
   PubMed Web of Science ®Google Scholar
• McPartland JM, Norris RW, Kilpatrick CW. Tempo and mode in the endocannabinoid system. J Mol Evol 2007;65:267-76
   PubMedGoogle Scholar
• Liu J, Wang L, Harvey-White J, A biosynthetic pathway for anandamide. Proc Natl Acad Sci 2006;103:13345-50
   PubMed Web of Science ®Google Scholar
• Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001;410:588-92
   PubMed Web of Science ®Google Scholar
• Hampson RE, Evans JG, Mu J, Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. Life Sci 1995;56:2081-8
   PubMedGoogle Scholar
• Mackie K, Hillie B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 1992;89:3825-9
   PubMed Web of Science ®Google Scholar
• Ueda N, Kurahashi Y, Yamamoto S, Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem 1995;270:23823-7
   PubMed Web of Science ®Google Scholar
• Tsuboi K, Sun YX, Okamoto Y, Molecular characterization of N-acylethanolamine -hydrolazing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 2005;280:11082-92
   PubMed Web of Science ®Google Scholar
• Dinh TP, Carpenter D, Lesile FM, Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002;99:10819-24
   PubMed Web of Science ®Google Scholar
• McFarland MJ, Barker EL. Anandamide transport. Pharmacol Ther 2004;104:117-35
   PubMedGoogle Scholar
• Hillard CJ, Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 2003;140:802-8
   PubMed Web of Science ®Google Scholar
• Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 2008;153:182-8
   PubMed Web of Science ®Google Scholar
• Klump KL, Kaye WH, Strober M. The evolving genetic foundations of eating disorders. Psychiatr Clin North Am 2001;24:215-25
   PubMed Web of Science ®Google Scholar
• Berry EM, Mechoulam R. Tetrahydrocannabinol endocannabinoids in feeding and appetite. Pharmacol Ther 2002;95:185-90
   PubMed Web of Science ®Google Scholar
• Cota D, Tschop MH, Horvath TL, Cannabinoids, opioids and eating behaviour: the molecular face of hedonism. Brain Res Rev 2006;51:85-107
   PubMed Web of Science ®Google Scholar
• Siegfield Z, Kanyas K, Latzer Y, Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and bingeing/purging subtypes. Am J Med Genet B Neuropsychiatr Genet 2004;125B:126-30
   PubMedGoogle Scholar
• Arias F, Ampuero I, Saqredo O, Lack of association between polymorphisms in cannabinoid receptor gene (CNR1) and fatty acid amide hydroxylase gene (FAAH) and eating disorders in a preliminary study. Phychiatric Genet 2009;19:336
   PubMed Web of Science ®Google Scholar
• Schroth GP, Chou PJ, Ho PS. Mapping Z-DNA in the human genome. Computer-aided mapping reveals a nonrandom distribution of potential Z-DNA-forming sequences in human genes. J Biol Chem 1992;267:11846-55
   PubMed Web of Science ®Google Scholar
• Monteleone P, Bifulco M, Di Filippo C, Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav 2009;8:728-32
   PubMed Web of Science ®Google Scholar
• Estourgie-van Burk GF, Bartels M, van Beijsterveldt TC, Body size in five-year-old twins: heritability and comparison to singleton standards. Twin Res Hum Genet 2006;9:646-55
   PubMed Web of Science ®Google Scholar
• Fox CS, Heard-Costa NL, Vasan RS, Framingham Heart Study. Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab 2005;90:3197-201
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48
   PubMed Web of Science ®Google Scholar
• Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 2007;18:129-40
   PubMed Web of Science ®Google Scholar
• Cota D Role of the endocannabinoid system in energy balance regulation and obesity. Front Horm Res 2008;36:135-45
   PubMedGoogle Scholar
• Eggan SM, Lewis DA. Immunocytochemical distribution of the cannabinoid receptor CB1 in the primate neocortex: a regional and laminar analysis. Cereb Cortex 2007;17:175-91
   PubMed Web of Science ®Google Scholar
• Jbilo O, Ravinet-Trilou C, Arnone M, The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005;19:1567-9
   PubMed Web of Science ®Google Scholar
• Jesudason D, Wittert G. Endocannabinoid system in food intake and metabolic regulation. Curr Opin Lipidol 2008;19:344-8
   PubMed Web of Science ®Google Scholar
• Pagano C, Pilon C, Calcaqno A, The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab 2007;92:4810-19
   PubMed Web of Science ®Google Scholar
• Baye TM, Zhang Y, Smith E, Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index. Pharmacogenomics 2008;9:1647-56
   PubMed Web of Science ®Google Scholar
• Bordicchia M, Battistoni I, Mancinelli L, CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. Metabolism 2010;59:734-41
   PubMed Web of Science ®Google Scholar
• Russo P, Strazzullo P, Cappuccio FP, Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. J Clin Endocrinol Metab 2007;92:2382-6
   PubMed Web of Science ®Google Scholar
• Jaeger JP, Mattevi VS, Callegari-Jacques SM, Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis Markers 2008;25:67-74
   PubMed Web of Science ®Google Scholar
• Hu WC, Feng P. G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population. Arch Med Res 2010;41:378-82
   PubMed Web of Science ®Google Scholar
• Muller TD, Reichwald K, Wermter AK, No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. Mol Genet Metab 2007;90:429-34
   PubMed Web of Science ®Google Scholar
• Aberle J, Fedderwitz I, Klages N, Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm Metab Res 2007;39:395-3977
   PubMedGoogle Scholar
• de Luis DA, Gonzalez Sagrado M, Aller R, Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity. Metabolism 2011;60:272-6
   PubMed Web of Science ®Google Scholar
• Benzinou M, Chevre JC, Ward KJ, Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum Mol Genet 2008;17:1916-21
   PubMed Web of Science ®Google Scholar
• Monteleone P, Milano W, Petrella C, Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. J Clin Psychopharmacol 2010;30:441-5
   PubMedGoogle Scholar
• Martin M, Ledent C, Parmentier M, Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002;159:379-87
   PubMed Web of Science ®Google Scholar
• Hill MN, Gorzalka BB. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav Pharmacol 2005;16:333-52
   PubMed Web of Science ®Google Scholar
• Adamczyk P, Golda A, McCreary AC, Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J Physiol Pharmacol 2008;59:217-28
   PubMed Web of Science ®Google Scholar
• Hill MN, Gorzalka BB. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol 2005;15:593-9
   PubMed Web of Science ®Google Scholar
• Monteleone P, Bifulco M, Maina G, Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol Res 2010;261:400-4
   Google Scholar
• Barrero FJ, Ampuero I, Morales B, Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 2005;5:135-41
   PubMed Web of Science ®Google Scholar
• Onaivi ES, Ishiquro H, Gong JP, Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One 2008;3:e1640
   PubMed Web of Science ®Google Scholar
• Juhasz G, Chase D, Pegg E, CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009;234:2019-27
   Google Scholar
• Ogborne AC, Smart RG, Weber T, Who is using cannabis as a medicine and why: an exploratory study. J Psychoactive Drugs 2000;32:435-43
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Haller J, Halasz J, One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J Neurosci 2003;17:1279-86
   PubMed Web of Science ®Google Scholar
• Lazary J, Lazary A, Gonda X, Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype. Am J Med Genet B Neuropsychiatr Genet 2009;150B:1118-27
   PubMed Web of Science ®Google Scholar
• Zhang PW, Ishiquro H, Ohtsuki T, Human cannabinoid receptor 1:5' exons candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 2004;9:916-31
   PubMed Web of Science ®Google Scholar
• Lu AT, Oqdie MN, Javerlin MR, Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147B(8):1488-94
   PubMed Web of Science ®Google Scholar
• Ujike H, Morita Y. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. Psychiatr Genet 2004;10:376-81
   Google Scholar
• Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001;178:116-22
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, Prospective cohort study of cannabis use, predisposion to psychosis, and psychotic symptoms in young people. BMJ 2005;330:11
   PubMed Web of Science ®Google Scholar
• Treffert DA. Marijuana use in schizophrenia: a clear hazard. Am J Psychiatry 1978;135:1213-15
   PubMed Web of Science ®Google Scholar
• Ujike H, Morita Y. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. J Pharmacol Sci 2004;96:376-81
   PubMedGoogle Scholar
• Ujike H, Takaki M, Nakata K, CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 2002;7:515-18
   PubMed Web of Science ®Google Scholar
• Zammit S, Spurlock G, Williams H, Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007;191:402-7
   PubMed Web of Science ®Google Scholar
• Seifert J, Ossege S, Emrich HM, No association of CNR1 gene variations with susceptibility to schizophrenia. Neurosci Lett 2007;426:29-33
   PubMed Web of Science ®Google Scholar
• Hamdani N, Tabeze JB, Ramoz N, The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Eur Neuropsychopharmacol 2008;18:34-40
   PubMed Web of Science ®Google Scholar
• Tsai SJ, Wang YC, Hong CJ. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet 2000;10:149-51
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Horiuchi Y, Ishikawa M, Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 2010;67:974-82
   PubMed Web of Science ®Google Scholar
• Giuffrida A, Parsons LH, Kerr TM, Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 1999;2:358-63
   PubMed Web of Science ®Google Scholar
• Manzanares J, Corcero J, Romero J, Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999;20:287-94
   PubMed Web of Science ®Google Scholar
• Lopez-Moreno JA, Lopez-Jimenez A, Gorriti MA, Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors. Curr Drug Targets 2010;11:406-28
   PubMed Web of Science ®Google Scholar
• Onaivi ES. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006;54:231-46
   PubMedGoogle Scholar
• Schmidt LG, Samochowiec J, Finckh U, Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 2002;65:221-4
   PubMed Web of Science ®Google Scholar
• Zuo L, Kranzler HR, Luo X, CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 2007;62:616-26
   PubMed Web of Science ®Google Scholar
• Zuo L, Kranzler HR, Luo X, Interaction between two independent CNR1 variants increases risk for cocaine dependence in European-Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology 2009;34:1504-13
   PubMed Web of Science ®Google Scholar
• Herman AI, Kranzler HR, Cubells JF, Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006;141B:499-503
   PubMed Web of Science ®Google Scholar
• Agrawal A, Wetherill L, Dick DM, Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am J Med Genet B Neuropsychiatr Genet 2009;150B:736-40
   PubMed Web of Science ®Google Scholar
• Hopfer CJ, Young SE, Purcell S, Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet B Neuropsychiatr Genet 2006;141B:895-901
   PubMed Web of Science ®Google Scholar
• Hartman CA, Hopfer CJ, Haberstick B, The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Drug Alcohol Depend 2009;104:11-16
   PubMed Web of Science ®Google Scholar
• Johnson JP, Muhleman D, McMurray J, Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential. Mol Psychiatry 1997;2:169-71
   PubMedGoogle Scholar
• Ballon N, Leroy S, Roy C, (AAT) repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics 2006;6:126-30
   Google Scholar
• Benyamina A, Kebir O, Blecha L, CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol 2011;16:1-6
   PubMed Web of Science ®Google Scholar
• Haughey HM, Marshall E, Schacht JP, Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 2008;103:1678-86
   PubMed Web of Science ®Google Scholar
• Filbey FM, Schacht JP, Myers US, Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology 2010;35:967-75
   PubMed Web of Science ®Google Scholar
• Chen X, Williamson WS, An SS, Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry 2008;65:816-24
   PubMed Web of Science ®Google Scholar
• Esfandyari T, Cammileri M, Busciqlio I, Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol 2007;293:137-45
   PubMed Web of Science ®Google Scholar
• Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med 2005;83:944-54
   PubMed Web of Science ®Google Scholar
• Kimball ES, Schneider CR, Wallace NH, Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am J Physiol Gastrointest Liver Physiol 2006;291:G364-71
   PubMed Web of Science ®Google Scholar
• Massa F, Marsicano G, Hermann H, Endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 2004;113:1202-9
   PubMed Web of Science ®Google Scholar
• Storr M, Emmerdinger D, Diegelmann J, The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One 2010;5:e9453
   Google Scholar
• Storr MA, Keenan CM, Emmerdinger D, Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 2008;86:925-36
   PubMed Web of Science ®Google Scholar
• Park JM, Choi M, Cho YK, Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. J Clin Gastroenterol 2011;45:45-9
   PubMedGoogle Scholar
• Siegmund SV, Schwabe RF. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008;294:357-62
   Google Scholar
• Akerman S, Holland PR, Goadsby PJ. Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther 2007;320:64-71
   PubMed Web of Science ®Google Scholar
• Akerman S, Kaube H, Goadsby PJ. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 2004;309:56-63
   PubMed Web of Science ®Google Scholar
• Juhasz G, Lazary J, Chase D, Variations in the cannabinoid receptor 1 gene predispose to migraine. Neurosci Lett 2009;461:116-20
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163(4):716-23
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT, Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005;162:1621-7
   PubMed Web of Science ®Google Scholar
• Woolmore J, Stone M, Holey S, Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis. Mult Scler 2008;14:177-82
   PubMed Web of Science ®Google Scholar
• Rossi S, Buttari F, Studer V, The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler 2011;17:281-8.
   PubMedGoogle Scholar
• Tam J, Trembovler V, Di Marzo V, The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 2008;22:285-94
   PubMed Web of Science ®Google Scholar
• Bab I, Zimmer A, Melamed E. Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Ann Med 2009;41:560-7
   PubMed Web of Science ®Google Scholar
• Huang QY, Li GH, Kung AW. Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese 2009. Bone 44:984-8
   PubMedGoogle Scholar
• Karsak M, Cohen-Solal M, Freudenberg J, Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 2005;14:3389-96
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int J Mol Med 2007;19:791-801
   PubMedGoogle Scholar
• Karsak M, Malkin I, Toliat MR, The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample. Hum Genet 2009;126:629-36
   PubMed Web of Science ®Google Scholar
• Steffens S, Veillard NL, Arnaud C, Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005;434:782-6
   PubMed Web of Science ®Google Scholar
• Reinhard W, Stark K, Neurether K, Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors. Int J Mol Med 2008;22:165-74
   PubMedGoogle Scholar
• Wang H, Guo Y, Wang D, Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med 2004;10:1074-80
   PubMed Web of Science ®Google Scholar
• Paria BC, Dey SK. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 2000;108:211-20
   PubMed Web of Science ®Google Scholar
• Paria BC, Song H, Wuang X, Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 2001;276:20523-8
   PubMed Web of Science ®Google Scholar
• Horne AW, Phillips AJ III, Kane N, CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy. PLoS One 2008;3:e3969
   PubMed Web of Science ®Google Scholar